"10.1371_journal.pgen.1002707","plos genetics","2012-06-07T00:00:00Z","Fanggeng Zou; High Seng Chai; Curtis S Younkin; Mariet Allen; Julia Crook; V Shane Pankratz; Minerva M Carrasquillo; Christopher N Rowley; Asha A Nair; Sumit Middha; Sooraj Maharjan; Thuy Nguyen; Li Ma; Kimberly G Malphrus; Ryan Palusak; Sarah Lincoln; Gina Bisceglio; Constantin Georgescu; Naomi Kouri; Christopher P Kolbert; Jin Jen; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg; Alzheimer's Disease Genetics Consortium; Ronald C Petersen; Neill R Graff-Radford; Dennis W Dickson; Steven G Younkin; Nilüfer Ertekin-Taner","Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America; Department of Biostatistics, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Biostatistics, Mayo Clinic, Jacksonville, Florida, United States of America; Microarray Core, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Molecular Physiology and Biophysics and Vanderbilt Center for Human Genetics Research, Vanderbilt University, Nashville, Tennessee, United States of America; Gertrude H. Sergievsky Center, Department of Neurology, and Taub Institute on Alzheimers Disease and the Aging Brain, Columbia University, New York, New York, United States of America; The John P. Hussman Institute for Human Genomics and Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, United States of America; Departments of Biostatistics, Medicine (Genetics Program), Ophthalmology, Neurology, and Epidemiology, Boston University, Boston, Massachusetts, United States of America; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America; Department of Neurology, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Neurology, Mayo Clinic, Jacksonville, Florida, United States of America","¶ Membership of the Alzheimers Disease Genetics Consortium (ADGC) is provided in the Acknowledgments.","NR Graff-Radford has served as a consultant to Codman and received grant support from Elan Pharmaceutical Research, Pfizer Pharmaceuticals, Medivation, and Forrest. RC Petersen has been a consultant to GE Healthcare and Elan Pharmaceuticals, has served on a data safety monitoring committee for Pfizer and Janssen Alzheimer Immunotherapy, and has provided a CME lecture for Novartis. ADGC Authors: T.D.B. received licensing fees from and is on the speakers bureau of Athena Diagnostics. M.R.F. receives research funding from BristolMyersSquibb Company, Danone Research, Elan Pharmaceuticals, Eli Lilly, Novartis Pharmaceuticals, OctaPharma AG, Pfizer, and Sonexa Therapeutics; receives honoraria as scientific consultant from Accera, Astellas Pharma US Inc., Baxter, Bayer Pharmaceuticals Corporation, BristolMyersSquibb, Eisai Medical Research, GE Healthcare, Medavante, Medivation, Merck, Novartis Pharmaceuticals, Pfizer, Prana Biotechnology, QR Pharma, The sanofi-aventis Group, and Toyama Chemical; and is speaker for Eisai Medical Research, Forest Laboratories, Pfizer, and Novartis Pharmaceuticals. A.M.G. has research funding from AstraZeneca, Pfizer and Genentech, and has received remuneration for giving talks at Pfizer and Genentech. R.C.P. is on the Safety Monitory Committee of Pfizer (Wyeth) and a consultant to the Safety Monitoring Committee at Janssen Alzheimers Immunotherapy Program (Elan), to Elan Pharmaceuticals, and to GE Healthcare. R.E.T. is a consultant to Eisai, Japan, in the area of Alzheimers genetics and a shareholder in, and consultant to, Pathway Genomics, San Diego, CA.","2012","06","Fanggeng Zou","FZ",32,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
